AWHLAspira Women's Health Inc.vs its industry peers
A metric-by-metric comparison of Aspira Women's Health Inc. against SIC 2835 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AWHLThis | — | — | — | — | 0.4%#4 | 2.4%#7 | -85.9%#2 | — | — | 3#2 | — | — |
| TKNO | $391M#1 | — | 6.3x#4 | 9.7x#5 | 7.4%#3 | 35.5%#2 | -41.9%#1 | -27.6%#1 | -25.2%#1 | 5#1 | 43.5%#1 | — |
| ICCC | $95M#2 | — | — | — | — | — | — | — | — | — | — | — |
| IMDX | $94M#3 | — | — | 23.2x#6 | 115.6%#1 | 17.2%#5 | -1260.8%#6 | — | — | — | -53.0%#2 | — |
| BMRA | $8M#4 | — | 2.2x#3 | 1.8x#2 | -16.2%#6 | 24.1%#3 | -119.5%#3 | -103.5%#4 | — | — | — | — |
| QCLS | $3M#5 | 0.0x#1 | 0.2x#2 | 2.2x#3 | -5.3%#5 | 50.2%#1 | -624.4%#4 | -72.3%#2 | -61.2%#2 | — | — | — |
| VNRX | $3M#6 | — | — | 1.5x#1 | 40.0%#2 | 13.4%#6 | -1258.5%#5 | — | — | — | -97.8%#3 | — |
| CDIOW | $40249#7 | — | 0.0x#1 | 2.7x#4 | -57.5%#7 | 22.5%#4 | -43737.5%#7 | -87.5%#3 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2835). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice